Wearable injector configurations provide a scalable framework for lifestyle-compatible medicine, utilizing electromechanical or osmotic pumps to regulate delivery dynamics for high-concentration monoclonal antibodies. The Africa Wearable Injectors Market share is expected to reach US$ 21.4 million by 2033 from US$ 9.6 million by 2025. The market is estimated to record a CAGR of 10.6%...